Castle Biosciences, Inc. (CSTL) Financials
CSTL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 458.5 million | 56.0 million |
2023-12-31 | 477.8 million | 86.5 million |
2023-09-30 | 436.0 million | 50.2 million |
2023-06-30 | 425.4 million | 46.6 million |
CSTL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -16.0 million | 12.7 million |
2023-12-31 | 20.3 million | 11.8 million |
2023-09-30 | 2.6 million | 13.0 million |
2023-06-30 | -7.8 million | 12.8 million |
CSTL Net Income
No data available :(
CSTL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 239.2 million | - | 15.1 million |
2023-12-31 | 243.1 million | - | 15.3 million |
2023-09-30 | 229.8 million | - | 14.5 million |
2023-06-30 | 225.5 million | - | 14.4 million |
CSTL Shares Outstanding
CSTL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 9.2 million | 13.5 million | 48.5 million | - |
2023-12-31 | 3.8 million | 12.9 million | 17.1 million | 27.0 million |
2023-09-30 | 2.5 million | 12.9 million | 16.1 million | 28.5 million |
2023-06-30 | 4.0 million | 13.3 million | 16.4 million | 28.3 million |
CSTL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 73.0 million | 16.6 million |
2023-12-31 | 66.1 million | 15.1 million |
2023-09-30 | 61.5 million | 11.3 million |
2023-06-30 | 50.1 million | 11.1 million |
CSTL
Price: $24.24
52 week price:
Earnings Per Share: -1.13 USD
P/E Ratio: -8.24
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 126500
Market Capitalization: 656.9 million